About Keratin-associated protein 10-4
Keratin-associated protein 10-4 (KRTAP10-4) is a protein
from Homo sapiens identified by UniProt accession
P60372, 401 residues long.
MolForge cross-references it against 0 known binders and
13 disease associations.
Target properties
| Protein name | Keratin-associated protein 10-4 |
| UniProt accession | P60372 |
| Gene | KRTAP10-4 |
| Organism | Homo sapiens |
| Length | 401 residues |
| Molecular weight | — |
| EC numbers | — |
| Target class | UNCLASSIFIED |
| Subcellular location | — |
| Keywords | — |
Druggability
Target tractability assessment (Open Targets + pocket analysis). No approved drug
| Druggability tier | MEDIUM |
| Druggability score | — |
| Pocket score | — |
| Max clinical phase | — |
Disease associations (13)
Diseases linked to this target (Open Targets).
- head and neck squamous cell carcinoma · score 0.18
- clear cell renal carcinoma · score 0.18
- glioblastoma multiforme · score 0.18
- prostate adenocarcinoma · score 0.18
- breast adenocarcinoma · score 0.18
- thyroid gland adenocarcinoma · score 0.16
- attention deficit hyperactivity disorder · score 0.06
- Tourette syndrome · score 0.05
- schizophrenia 15 · score 0.04
- Phelan-McDermid syndrome · score 0.04
3D Structure (1)
Experimental (PDB) and predicted (AlphaFold) structures for this protein.
| Structure | Source | Method | Mean pLDDT | Resolution (Å) |
| AF-P60372-F1 | alphafold | PREDICTED | 35.42 | — |
Amino-acid sequence (401 residues)
MSVCSSDLSY SSRVCLPGSC DSCSDSWQVD DCPESCCEPP CCAPSCCAPA PCLSLVCTPV SRVSSPCCPV TCEPSPCQSG CTSSCTPSCC QQSSCQLACC ASSPCQQACC VPVCCKTVCC KPVCCVPVCC GDSSCCQQSS CQSACCTSSP CQQACCVPIC CKPVCSGISS SCCQQSSCVS CVSSPCCQAV CEPSPCQSGC ISSCTPSCCQ QSSCQPACCT SSSCQQACCV PVCCKTVCCK PVCSEDSSSC CQQSSCQPAC CTSSPCQQAC CVPVCCKPVC CKPVCSVPIC SGASSLCCQQ SSCQPACCTS SQSQQGCCVP VCCKPVSCVP VCSGASSSCC QQSSCQPACC TTSCCRPSSS VSLLCRPVCR PACCVPVPSC CAPTSSCQPS CCRPASCVSL L
Explore Keratin-associated protein 10-4 with MolForge
Find binders, run structure-based screening, and map this target across
diseases and approved drugs with our AI-powered platform.
Browse all targets